SFE Investment Counsel decreased its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 18.9% during the second quarter, according to its most recent filing with the SEC. The firm owned 64,658 shares of the pharmacy operator’s stock after selling 15,090 shares during the period. Walgreens Boots Alliance accounts for about 2.1% of SFE Investment Counsel’s portfolio, making the stock its 17th largest position. SFE Investment Counsel’s holdings in Walgreens Boots Alliance were worth $5,063,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of WBA. State Street Corp grew its position in Walgreens Boots Alliance by 1.8% during the 1st quarter. State Street Corp now owns 37,612,843 shares of the pharmacy operator’s stock worth $3,123,757,000 after purchasing an additional 677,743 shares during the last quarter. Wellington Management Group LLP lifted its stake in Walgreens Boots Alliance by 5.9% during the 1st quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock valued at $2,727,932,000 after acquiring an additional 1,824,300 shares during the period. Nordea Investment Management AB lifted its stake in Walgreens Boots Alliance by 26.5% during the 1st quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock valued at $760,267,000 after acquiring an additional 1,917,082 shares during the period. TIAA CREF Investment Management LLC lifted its stake in Walgreens Boots Alliance by 22.4% during the 1st quarter. TIAA CREF Investment Management LLC now owns 5,269,500 shares of the pharmacy operator’s stock valued at $437,632,000 after acquiring an additional 962,959 shares during the period. Finally, UBS Asset Management Americas Inc. lifted its stake in Walgreens Boots Alliance by 22.9% during the 1st quarter. UBS Asset Management Americas Inc. now owns 4,912,489 shares of the pharmacy operator’s stock valued at $407,982,000 after acquiring an additional 914,888 shares during the period. 60.16% of the stock is currently owned by institutional investors and hedge funds.

Shares of Walgreens Boots Alliance, Inc. (WBA) opened at 69.00 on Friday. The stock has a market cap of $73.84 billion, a price-to-earnings ratio of 17.42 and a beta of 1.25. The company has a 50 day moving average of $78.72 and a 200-day moving average of $80.77. Walgreens Boots Alliance, Inc. has a one year low of $68.55 and a one year high of $88.00.

Walgreens Boots Alliance declared that its Board of Directors has authorized a stock repurchase plan on Thursday, June 29th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the pharmacy operator to buy up to 5.9% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s management believes its stock is undervalued.

WBA has been the subject of several research reports. Loop Capital started coverage on shares of Walgreens Boots Alliance in a research note on Thursday, August 24th. They set a “buy” rating and a $95.00 price objective for the company. Needham & Company LLC restated a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a research report on Sunday, September 10th. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, September 12th. Jefferies Group LLC restated a “buy” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, September 7th. Finally, Credit Suisse Group restated a “buy” rating and set a $97.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $91.31.

ILLEGAL ACTIVITY NOTICE: This report was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at https://www.thecerbatgem.com/2017/10/13/sfe-investment-counsel-cuts-holdings-in-walgreens-boots-alliance-inc-wba.html.

In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the transaction, the director now owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.